Noninvasive colorectal cancer screening commenced historically with the use of
guaiacbased tests that require the addition of hydrogen peroxide to oxidize the presence of …

Background Blood-based biomarker tests can potentially change the landscape of colorectal
cancer (CRC) screening. We characterize the conditions under which blood test screening …

Gastrointestinal (GI) cancers are a leading cause of cancer morbidity and mortality. 1 In the
United States, GI cancers are predicted to lead to over 170,000 deaths in 2023 alone …

Technological advancements in cell-free DNA (cfDNA) liquid biopsy have triggered
exponential growth in numerous clinical applications. While cfDNA-based liquid biopsy has …

Objective This analysis estimated the outcomes of triennial blood-based colorectal cancer
(CRC) screening at various adherence, including perfect adherence, compared with …

Cell-free DNA (cfDNA) analysis has several promising clinical applications in the
management of cancer patients, with clinical validity established in different types of solid …

In this issue of JAMA, Feng et al studied whether late-stage cancer (ie, stage III or stage IV
cancer), rather than cancerspecific mortality, was an acceptable alternative end point in …

Aim To assess the efficacy of ctDNA measurement at different time intervals in predicting
response and prognosis in patients diagnosed with locally advanced rectal cancer (LARC) …

In this editorial we comment on the article by Agatsuma et al published in the World Journal
of Gastroenterology. They suggest policies for more effective colo rectal screening …